Tweet Archive for February 2019 « page 6
P8076 – Patient knowledge of FDA-mandated sunscreen labeling terminology: a cross-sectional survey
P8089 – UVA1 Pho…
https://twitter.com/i/web/status/1100709734137675777
My selection of #AAD2019 posters – Photobiology
P8033 – Project “Get the Block”: A Unique Sunscreen Use Program Inv…
https://twitter.com/i/web/status/1100709732485083137
P8264 – Clinical Efficacy & Safety of Oral Polypodium Leucotomos Extract for Photoprotection: A Systematic Review
P…
https://twitter.com/i/web/status/1100709735211384832
P10063 – Phase1 & Phase2 studies evaluating the MoA, safety, efficacy of Clascoterone in Androgenetic Alopecia
P105…
https://twitter.com/i/web/status/1100704528469508096
P10029 – Relapsing drug induced hypersensitivity syndrome following bortezomib for multiple myeloma
P8359 – Cutaneo…
https://twitter.com/i/web/status/1100704527127334913
P8259 – Dilute intralesional 5-FU for the treatment of nonmelanoma skin cancer: A case series
P8299 – Olmesartan-In…
https://twitter.com/i/web/status/1100704523729948673
P8696 – Palladium based nanoparticles for the treatment of advanced melanoma
P8501 – Intertriginous and photodistri…
https://twitter.com/i/web/status/1100704524795297792
P10021 – Dupilumab-Induced Psoriasiform Dermatitis
P10359 – Unusual Progression to Erythroderma After Initiation of…
https://twitter.com/i/web/status/1100704525952913408
P8127 – A case of methotrexate-induced epidermal necrosis
P8469 – Methotrexate induced ulcerations in a patient wit…
https://twitter.com/i/web/status/1100704522408812545
My selection of #AAD2019 posters – Pharmacology
P8011 – Abatacept-induced panniculitis in a patient with rheumatoid…
https://twitter.com/i/web/status/1100704520395460608